Levodopa-induced Dyskinesia Market DelveInsight’s analysts project market growth, fueled by increasing prevalence, improved diagnostics,...
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - MOUNTAINTODAY.IN - A La Une - 08/Jul 18:52
Pancreatic Cancer Pipeline 2024 | ERYtech Pharma, Jiangsu HengRui Medicine Co., Ltd., FibroGen, Novartis AG, AB Science, Eleison Pharmaceuticals, Cornerstone Pharmaceuticals, Panbela Therapeutics
DelveInsight’s, “Pancreatic Cancer Pipeline Insight 2024” report provides comprehensive insights about 290+ companies and 300+ pipeline drugs in the Pancreatic Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage
Articles similaires
Levodopa-induced Dyskinesia Market Growth Anticipated by 2032 | Companies includes Adamas Pharmaceuticals, Acorda Therapeutics, Impel NeuroPharma, Neurocrine Biosciences, Kyowa Kirin, Sunovion Pharma
mountaintoday.in - 08:52
Levodopa-induced Dyskinesia Market DelveInsight’s analysts project market growth, fueled by increasing prevalence, improved diagnostics,...
United States Dominates Global Pancreatic Cancer Market with 50% Share, Outpacing EU4, UK, and Japan, DelveInsight | AstraZeneca, Merck Sharp & Dohme LLC, Bayer, Roche, Celgene, Bristol Myers Squibb
mountaintoday.in - 06/Sep 07:33
Pancreatic Cancer Market As per DelveInsight, the Pancreatic Cancer Market is anticipated to grow immensely in the coming years owing to the launch of...
Iron Deficiency Anemia Market Analysis 2034 | Iron Deficiency Anemia Therapies, Clinical trials, Iron Deficiency Anemia prevalence, Treatment Algorithms | Akebia Therapeutics, Shield Therapeutics
mountaintoday.in - 04/Sep 08:17
Iron Deficiency Anemia Market As per DelveInsight, the Iron Deficiency Anemia Market is anticipated to grow immensely in the coming years owing to the...
Iron Deficiency Anemia Market Analysis 2034 | Iron Deficiency Anemia Therapies, Clinical trials, Iron Deficiency Anemia prevalence, Treatment Algorithms | Akebia Therapeutics, Shield Therapeutics
mountaintoday.in - 04/Sep 08:17
Iron Deficiency Anemia Market As per DelveInsight, the Iron Deficiency Anemia Market is anticipated to grow immensely in the coming years owing to the...
Relay Therapeutics reports positive interim data for RLY─2608 demonstrating clinically meaningful progression free survival
pharmabiz.com - 10/Sep 00:00
Relay Therapeutics, Inc., a clinical─stage precision medicine company transforming the drug discovery process by combining leading─edge...
Huntington’s Disease Market Forecast 2034: Therapies, Clinical trials, prevalence, Treatment Algorithms by DelveInsight | MicuRx, Basilea pharmaceuticals, AbbVie, Cubist Pharms LLC, Nabriva Therapeuti
mountaintoday.in - 04/Sep 07:21
Huntington’s Disease Market As per DelveInsight, the Huntington’s Disease Market is anticipated to grow immensely in the coming years...
Huntington’s Disease Market Forecast 2034: Therapies, Clinical trials, prevalence, Treatment Algorithms by DelveInsight | MicuRx, Basilea pharmaceuticals, AbbVie, Cubist Pharms LLC, Nabriva Therapeuti
mountaintoday.in - 04/Sep 07:21
Huntington’s Disease Market As per DelveInsight, the Huntington’s Disease Market is anticipated to grow immensely in the coming years...
Researchers identify key markers in pancreatic cancer progression using a new analysis pipeline
oncologynews.com.au - 02/Sep 15:57
Using a new workflow that integrates spatial transcriptomics and machine learning for imaging analysis and integration with single-cell datasets,...
Interstitial Cystitis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest EMA, PDMA, FDA Approvals by DelveInsight | Merck & Co, Teva Pharmaceutical Industries, Integrative Therapeutics
mountaintoday.in - 04/Sep 07:57
Interstitial Cystitis market The Interstitial Cystitis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)....
Les derniers communiqués
-
Aucun élément